New York, London, Munich, Dubai – August 22, 2024 – DataArt, a global software engineering firm, announced today that it has been recognized in the Gartner Hype Cycle™ for Life Science Clinical Development, 2024. This is the fourth consecutive year that DataArt has been identified as a Sample Vendor for the AI in Clinical Development category in the Gartner Hype Cycle for Life Science Clinical Development, 2024 report.
For DataArt, being mentioned as a Sample Vendor for the AI in Clinical Development category means that the company is at the forefront of leveraging AI to streamline trial timelines, reduce staffing needs, and, most importantly, increase visibility into trial activities. This enhances risk assessment and overall trial quality and shows a significant opportunity for the company.
Daniel Piekarz, SVP and Head of Healthcare & Life Sciences at DataArt, said:
“We consider this recognition by Gartner an accomplishment. The recent advancements in Artificial Intelligence are a massive catalyst in clinical development for companies that have spent the time to ensure their data is empowering and enabling AI initiatives. These innovations will accelerate drug discovery and bring life-saving treatments to patients much faster than ever before. We are entering a whole new era of clinical development.”
According to Gartner,
“This Hype Cycle explores innovative technologies that are specifically relevant to clinical development programs in the pharmaceutical, biotechnology, diagnostics, medical device, research institution and contract research sectors. This year, we have simplified the Hype Cycle, including only the innovations that are unique to clinical development, with a few exceptions. The exceptions include generative AI in life science, digital life science platforms, and data fabric in healthcare and life sciences (HCLS).”
For more information, please visit gartner.com.
Gartner, Hype Cycle for Life Science Clinical Development, 2024, Jeff Smith, 13 August 2024
GARTNER is a registered trademark and service mark, and HYPE CYCLE is a registered trademark of Gartner, Inc. and/or its affiliates and are used herein with permission. All rights reserved.
Gartner does not endorse any vendor, product or service depicted in its research publications and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s Research & Advisory organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.
